291 related articles for article (PubMed ID: 22361401)
1. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation.
Eleid MF; Blauwet LA; Cha YM; Connolly HM; Brady PA; Dearani JA; Espinosa RE
J Am Coll Cardiol; 2012 Feb; 59(9):813-8. PubMed ID: 22361401
[TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic tricuspid valve dysfunction in patients with transvalvular or epicardial pacing leads.
Shafquat A; Salahuddin N; Aldawood W; Alassas K; Al-Ghamdi B; Fadel BM
Pacing Clin Electrophysiol; 2018 Nov; 41(11):1495-1499. PubMed ID: 30221784
[TBL] [Abstract][Full Text] [Related]
3. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
[TBL] [Abstract][Full Text] [Related]
4. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
[TBL] [Abstract][Full Text] [Related]
6. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
Lee RC; Friedman SE; Kono AT; Greenberg ML; Palac RT
Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
[TBL] [Abstract][Full Text] [Related]
7. Transvalvular pacemaker leads increase the recurrence of regurgitation after tricuspid valve repair.
Mazine A; Bouchard D; Moss E; Marquis-Gravel G; Perrault LP; Demers P; Carrier M; Cartier R; Pellerin M
Ann Thorac Surg; 2013 Sep; 96(3):816-22. PubMed ID: 23866803
[TBL] [Abstract][Full Text] [Related]
8. Tricuspid Regurgitation following Lead Extraction: Risk Factors and Clinical Course.
Givon A; Vedernikova N; Luria D; Vatury O; Kuperstein R; Feinberg MS; Eldar M; Glikson M; Nof E
Isr Med Assoc J; 2016 Jan; 18(1):18-22. PubMed ID: 26964274
[TBL] [Abstract][Full Text] [Related]
9. Optimal surgical management of severe tricuspid regurgitation in cardiac transplant patients.
Filsoufi F; Salzberg SP; Anderson CA; Couper GS; Cohn LH; Adams DH
J Heart Lung Transplant; 2006 Mar; 25(3):289-93. PubMed ID: 16507421
[TBL] [Abstract][Full Text] [Related]
10. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads.
Kucukarslan N; Kirilmaz A; Ulusoy E; Yokusoglu M; Gramatnikovski N; Ozal E; Tatar H
J Card Surg; 2006; 21(4):391-4. PubMed ID: 16846419
[TBL] [Abstract][Full Text] [Related]
11. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
[TBL] [Abstract][Full Text] [Related]
12. [Tricuspid regurgitation induced by transvenous right ventricular pacing: echocardiographic and pathological observations].
Sakai M; Ohkawa S; Ueda K; Kin H; Watanabe C; Matsushita S; Kuramoto K; Sugiura M; Takahashi T; Takenaka K
J Cardiol; 1987 Jun; 17(2):311-20. PubMed ID: 3448170
[TBL] [Abstract][Full Text] [Related]
13. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
[TBL] [Abstract][Full Text] [Related]
14. [Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation].
Ren CL; Wang Y; Wang R; Li BJ; Geng RY; Gao CQ
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2118-22. PubMed ID: 23158275
[TBL] [Abstract][Full Text] [Related]
15. The impact of transvenous lead extraction on tricuspid valve function.
Coffey JO; Sager SJ; Gangireddy S; Levine A; Viles-Gonzalez JF; Fischer A
Pacing Clin Electrophysiol; 2014 Jan; 37(1):19-24. PubMed ID: 23991637
[TBL] [Abstract][Full Text] [Related]
16. Do transvalvular pacemaker leads influence functional outcome after tricuspid ring annuloplasty?
Ratschiller T; Guenther T; Knappich C; Guenzinger R; Kehl V; Voss B; Lange R
Eur J Cardiothorac Surg; 2015 Sep; 48(3):363-9. PubMed ID: 25425555
[TBL] [Abstract][Full Text] [Related]
17. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
[TBL] [Abstract][Full Text] [Related]
18. Tricuspid regurgitation and implantable devices.
Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
[TBL] [Abstract][Full Text] [Related]
19. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
Alnaimat S; Doyle M; Krishnan K; Biederman RWW
Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA
Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
